Faculty profile

Mariana Etchebarne

Back to faculty

Associate ProfessorInfectious Disease Research CentreUniversité Laval

Mariana Etchebarne

Associate Professor

Infectious Disease Research Centre

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
45 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

102

Publications

2,498

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université Laval profile.

Sciences naturelles Sciences biologiques Microbiologie Virologie Sciences médicales, de la santé et de la vie Médecine fondamentale et sciences de la vie Microbiologie médicale Virologie médicale Résistance aux antiviraux Vaccins Pathogenèse Microbiologie médicale, n.c.a.

Latest papers

Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia.
NPJ vaccines · 2026
A Multidimensional Immune Signature Predicts Susceptibility to Omicron Infection in Vaccinated Individuals
medRxiv · 2026
Dynamics of neutralizing antibodies against enterovirus D68 in adults during the COVID-19 pandemic.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026 · senior author

All 102 publications

102 publications.

Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia.

Nantel S, Sassine S, Bourdin B, Barbosa Da Torre M, Sutton G, Rabezanahary H, Qi F, Ward LA, Delgado-Brand M, Adams K, Sheikh-Mohamed S, Wang L, Nicholson S, Laghdir Z, Colwill K, Chao G, Seifried L, Liu Y, Rini JM, Gommerman J, Gingras AC, Baz M, Zinzser K, Quach C, Decaluwe H

NPJ vaccines20261 citationsOpen Access

DOI: 10.1038/s41541-026-01525-6 PMID: 42477358

A Multidimensional Immune Signature Predicts Susceptibility to Omicron Infection in Vaccinated Individuals

Hend Jarras, Wilfried Wenceslas Bazié, Isalie Blais, Benjamin Goyer, Julien Boucher, Arielle Pakenham, Kimberly Dancause-Caron, Henintsoa Rabezanahary, Mathieu Thériault, Kim Santerre, Marc‐André Langlois, Philippe A. Tessier, Jean‐François Masson, Joelle N. Pelletier, Nicholas Brousseau, Denis Boudreau, Sylvie Trottier, Mariana Baz, Caroline Gilbert

medRxiv2026Open Access

DOI: 10.64898/2026.08.31.26361844

Dynamics of neutralizing antibodies against enterovirus D68 in adults during the COVID-19 pandemic.

Rahajamanana VL, Rabezanahary H, Arroyave A, Wantchecon A, Theriault M, Gilbert C, Trottier S, Isabel S, Baz M

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2026Senior authorOpen Access

DOI: 10.1016/j.ijid.2026.109008 PMID: 42508523

PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines.

Bolduc M, Saint-Louis P, Carignan D, Garneau C, Breton Y, Pelletier M, Rancourt A, Satoh MS, Sato S, Gilbert M, Rabezanahary H, Baz M, Dubuc I, Flamand L, Leclerc D

Nanomedicine : nanotechnology, biology, and medicine2026

DOI: 10.1016/j.nano.2025.102887 PMID: 41354257

Preserved T-Cell Immunity Despite Impaired Humoral Responses following SARS-CoV-2 Infection and Vaccination in Children with Profound B-cell Lymphopenia

Sabryna Nantel, Samuel Sassine, Benoîte Bourdin, Margot Barbosa Da Torre, Gabrielle Sutton, Henintsoa Rabezanahary, Freda Qi, Lesley A. Ward, Melanie Delgado-Brand, Kelsey L. Adams, Salma Sheikh-Mohamed, Louise Wang, Sylvie Nicholson, Zineb Laghdir, Karen Colwill, Gary Chao, Laurie A. Seifried, Ying Liu, James M. Rini, Jennifer Gommerman, Anne‐Claude Gingras, Mariana Baz, Kate Zinzser, Caroline Quach, Hélène Decaluwe

Research Square2026Open Access

DOI: 10.21203/rs.3.rs-8864462/v1

Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.

Blanchette LJ, Bolduc M, Woldemariam T, Yousefi M, Rabezanahary H, Olivera-Ugarte SM, Garneau C, Angers M, Shi R, Flamand L, Baz M, Vidal S, Falzarano D, Lemay JF, Leclerc D

Vaccines2026Open Access

DOI: 10.3390/vaccines14040349 PMID: 42042825

Baloxavir and molnupiravir protect against severe influenza A(H5N1) infection in immunosuppressed hamsters

Mariana Baz, Andrea Arroyave, Henintsoa Rabezanahary, Ahmed Sahli

Research Square2026First authorOpen Access

DOI: 10.21203/rs.3.rs-9193430/v2

Baloxavir and molnupiravir protect against severe A/H5N1 infection in immunosuppressed hamsters

Mariana Baz, Andrea Arroyave, Henintsoa Rabezanahary, Ahmed Sahli

Research Square2026First authorOpen Access

DOI: 10.21203/rs.3.rs-9193430/v1

Longitudinal screening of retail milk from Canadian provinces reveals no detections of influenza A virus RNA (April-July 2024): leveraging a newly established pan-Canadian network for responding to emerging viruses.

Wallace HL, Wight J, Baz M, Dowding B, Flamand L, Hobman T, Jean F, Joy JB, Lang AS, MacParland S, McCormick C, Noyce R, Russell RS, Sagan SM, Snyman J, Rzeszutek GJ, Jafri MS, Bogoch I, Kindrachuk J, Rasmussen AL

Canadian journal of microbiology202513 citationsOpen Access

DOI: 10.1139/cjm-2024-0120 PMID: 39332021

Advances in the Treatment of Enterovirus-D68 and Rhinovirus Respiratory Infections.

Rahajamanana VL, Thériault M, Rabezanahary H, Sahnoun YG, Mallet MC, Isabel S, Trottier S, Baz M

Infectious disease reports20254 citationsSenior authorOpen Access

DOI: 10.3390/idr17030061 PMID: 40559192

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Mariana Etchebarne

Research

Latest papers

Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia.

A Multidimensional Immune Signature Predicts Susceptibility to Omicron Infection in Vaccinated Individuals

Dynamics of neutralizing antibodies against enterovirus D68 in adults during the COVID-19 pandemic.

PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines.

Preserved T-Cell Immunity Despite Impaired Humoral Responses following SARS-CoV-2 Infection and Vaccination in Children with Profound B-cell Lymphopenia

Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.

Baloxavir and molnupiravir protect against severe influenza A(H5N1) infection in immunosuppressed hamsters

Baloxavir and molnupiravir protect against severe A/H5N1 infection in immunosuppressed hamsters

Longitudinal screening of retail milk from Canadian provinces reveals no detections of influenza A virus RNA (April-July 2024): leveraging a newly established pan-Canadian network for responding to emerging viruses.

Advances in the Treatment of Enterovirus-D68 and Rhinovirus Respiratory Infections.

Frequent collaborators

Mariana Baz Etchebarne

Guy Boivin

Caroline Gilbert

Denis Boudreau

Kanta Subbarao

Joelle Pelletier

Jean-François Masson

Louis Flamand

Gaston De Serres

Denis Leclerc

Marc-André Langlois

Caroline Quach

Hélène Decaluwe

Andrew Lang

Craig McCormick

Tom Hobman

Isaac Bogoch

Gary Kobinger

François Jean

Sonya MacParland